Agilent has announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the US Food and Drug Administration.
Agilent has announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the US Food and Drug Administration. Both instruments are manufactured at medical device establishments with the FDA, which is a requirement for manufacturing medical devices.
Gustavo Salem, vice president and general manager, Biological Systems Division, said, “The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds tremendous value for the medical community. We’re being very methodical in bringing this technology to the clinic, while ensuring that the equipment meets the laboratories’ needs.”
For more information please visit ref="http://www.agilent.com">www.agilent.com
Determining the Effects of ‘Quantitative Marinating’ on Crayfish Meat with HS-GC-IMS
April 30th 2025A novel method called quantitative marinating (QM) was developed to reduce industrial waste during the processing of crayfish meat, with the taste, flavor, and aroma of crayfish meat processed by various techniques investigated. Headspace-gas chromatography-ion mobility spectrometry (HS-GC-IMS) was used to determine volatile compounds of meat examined.